Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCA

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 30, 2020

Study Completion Date

May 5, 2020

Conditions
Atrial Fibrillation
Interventions
DEVICE

Circa™ Probe

The Circa™ probe will be used to monitor esophageal temperature and guide ablation power and duration during the RFCA procedure. Following ablation esophagoscopy will be performed to assess for esophageal lesions.

Trial Locations (1)

92037

Sulpizio Cardiovascular Center, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Circa Scientific, Inc.

INDUSTRY

lead

University of California, San Diego

OTHER